TICKERNOMICS Sign up
Last Update: 2023-10-04 11:37:09
Metacrine Inc. ( MTCR ) https://www.metacrine.com
0.00USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
-99.71%
MTCR
SPY
36.71%
-99.99%
MTCR
SPY
70.96%
MTCR
0.00%
SPY
262.36%
MTCR
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.06
-38.90
0.08
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.00
7449.67
0.00
-130.50
0.00
0.00
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-72062500.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.69
-45.07
-33.66
0.00
Other Earnings and Cash Flow Stats:
Metacrine Inc. ( MTCR ) Net Income TTM ($MM) is -50.89
Metacrine Inc. ( MTCR ) Operating Income TTM ($MM) is -48.82
Metacrine Inc. ( MTCR ) Owners' Earnings Annual ($MM) is 0.00
Metacrine Inc. ( MTCR ) Current Price to Owners' Earnings ratio is 0.00
Metacrine Inc. ( MTCR ) EBITDA TTM ($MM) is -48.32
Metacrine Inc. ( MTCR ) EBITDA Margin is 0.00%
Capital Allocation:
Metacrine Inc. ( MTCR ) has paid 0.00 dividends per share and bought back 0.0 million shares in the past 12 months
Metacrine Inc. ( MTCR ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Metacrine Inc. ( MTCR ) Interest-bearing Debt ($MM) as of last quarter is 13
Metacrine Inc. ( MTCR ) Annual Working Capital Investments ($MM) are -3
Metacrine Inc. ( MTCR ) Book Value ($MM) as of last quarter is 37
Metacrine Inc. ( MTCR ) Debt/Capital as of last quarter is 37%
Other Balance Sheet Stats:
Metacrine Inc. ( MTCR ) has 52 million in cash on hand as of last quarter
Metacrine Inc. ( MTCR ) has 4 million of liabilities due within 12 months, and long term debt 13 as of last quarter
Metacrine Inc. ( MTCR ) has 42 common shares outstanding as of last quarter
Metacrine Inc. ( MTCR ) has 0 million USD of preferred stock value
Academic Scores:
Metacrine Inc. ( MTCR ) Altman Z-Score is 0.00 as of last quarter
Metacrine Inc. ( MTCR ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Metacrine Inc. ( MTCR ) largest shareholder is Tower Research Capital LLC owning 0 shares at 0.00 ($MM) value
Preston Klassen(an insider) Sold 380605 shares of Metacrine Inc. ( MTCR ) for the amount of $156048.05 on 2023-01-26
14.78% of Metacrine Inc. ( MTCR ) is held by insiders, and 37.13% is held by institutions
Metacrine Inc. ( MTCR ) went public on 2020-09-16
Other Metacrine Inc. ( MTCR ) financial metrics:
FCF:-41.38
Unlevered Free Cash Flow:-18.61
EPS:-0.50
Operating Margin:-72062500.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-57.50
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Metacrine Inc. ( MTCR ) :
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.